HOWARD J. SCHWARTZ, M.D.; FRANCIS C. LOWELL, M.D., F.A.C.P.; JAMES C. MELBY, M.D.
SCHWARTZ HJ, LOWELL FC, MELBY JC. Steroid Resistance in Bronchial Asthma. Ann Intern Med. 1968;69:493-499. doi: 10.7326/0003-4819-69-3-493
Download citation file:
Published: Ann Intern Med. 1968;69(3):493-499.
The eosinopenic response to 40 mg of cortisol given intravenously was studied in 19 unselected asthmatics (group A) and in 6 asthmatics who exhibit clinical resistance to cortisol's antiasthma effect (group B). The changes in total eosinophil counts were -35%, -77%, and -73% in group A; and -10%, -36%, and 3.6% in group B at 2, 4, and 6 hr after administration.
Cortisol turnover studies in four subjects from each group were done using a tracer dose of tritium-labeled cortisol immediately followed by 40 mg of unlabeled cortisol intravenously. Plasma levels were measured at 30, 60, 90, and 120 min; 6-hr urine collections were made. Cortisol half-life values in group A were 123, 133, 120, and 132 min; in group B they were 81, 96, 75, and 90 min.
Thus, asthma requiring unusually large doses of steroid for control may be associated with a decreased eosinopenic response to cortisol and an accelerated plasma cortisol clearance.
Learn more about subscription options.
Register Now for a free account.
Pulmonary/Critical Care, Asthma.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only